vitespen

BIOLOGICAL2 trials

Sponsors

Memorial Sloan Kettering Cancer Center

Conditions

Pancreatic CancerSarcoma

Phase 1

Vaccine Therapy in Treating Patients With Stage I or Stage II Pancreatic Cancer

CompletedNCT00003025

Memorial Sloan Kettering Cancer CenterPancreatic Cancer

Start: 1997-03-31End: 2002-07-31Target: 16Updated: 2013-07-03

Phase 2

Vaccine Therapy in Treating Patients With Recurrent Soft Tissue Sarcoma

CompletedNCT00005628

Memorial Sloan Kettering Cancer CenterSarcoma

Start: 1999-11-30End: 2001-08-31Updated: 2013-06-19